Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2017, Vol. 22 ›› Issue (11): 1259-1264.

Previous Articles     Next Articles

Inhibitory effects of eplerenone on the mRNA and protein expression of Kv1.3 and other channels of CD4+T lymphocyte in patients with chronic heart failure

LI Shaohua 1, YILI Hamujiang·KE Youmu 2, XU QI 3, SHAO Peipei 1, CHENG Lufeng 1   

  1. 1 Department of Pharmacology, School of Basic Medicine; 2 Department of Cardiology, the First Affiliated Hospital; 3 Department of Immunology, School of Basic Medicine, Urumqi 830011, Xinjiang, China
  • Received:2017-07-05 Revised:2017-08-10 Online:2017-11-26 Published:2017-12-11

Abstract:

AIM: To investigate the reversing effect of eplerenone on chronic heart failure through regulating the Kv1.3 channel of CD4+ T lymphocytes. METHODS: Thirty cases of chronic heart failure as CHF group and twenty cases of normal people as control group were collected from the First Affiliated Hospital of Xinjiang Medical University. CD4+ T lymphocyte was sorted by using immune magnetic bead which separated from peripheral blood, and its purity was tested by flow cytometry. The minimum effective concentration of EPL incubation CD4+ T lymphocyte proliferation was found by the CCK-8 technic; Control group, CHF group and CHF + EPL group were established. The expression of channel gene, Kv1.3, KCa3.1 and CRAC on the CD4+ T cell membrane were detected with RT-qPCR technique. And the protein expression of Kv1.3 channels on CD4+ T cell was detected by Western blot. RESULTS: 30 μmol/L was detedted as the prefect concentration for EPL. Compared with control group, the expression of mRNA and protein for Kv1.3 channel in CHF group were increased 10.74 times and 1.20 times, respectively (P<0.01), while that in the EPL+CHF group was decreased by 64.80%  and 39.62%, respectively (P<0.01); the mRNA expressions of KCa3.1 and CRAC channel were also increased 4.73 times and 3.77 times, respectively in CHF group (P<0.01) but it decreased after exposed to EPL (decreased by 19.30% and 37.14%,P<0.01). CONCLUSION: Eplerenone can down-regulate the expression of Kv1.3, KCa3.1 and CRAC channel, especial the Kv1.3, which in accordance with higher expression of the three channels protein on the CD4+ T cell separated from CHF patients. And the aldosterone antagonist may inhibit the actibation of Kv1.3 membrane channel on the CD4+ T cell, which is beneficial for the CHF.

Key words: chronic heart failure, CD4+ T lymphocytes, eplerenone, Kv1.3 channel, inhibition

CLC Number: